相关实验视频

Updated: Jun 11, 2025

Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry

Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry

Published on: February 2, 2024

基于生物活性的分析和从Heliteres angustifoliaL L的低血糖成分的化学表征

Xiaoli Tian¹, Yu Zhao¹, Ayu Zhang¹

¹School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, China.

Chemistry & biodiversity

|October 5, 2024

概括

赫利特雷斯士叶提取物 (HAEF) 通过抑制α-葡萄糖酶,有效降低糖尿病大鼠的血糖. 这项研究确定了H. angustifolia根中的关键低血糖化合物,用于糖尿病治疗.

科学领域:

药理学药理学是指药理学的学科.
自然产品化学化学
糖尿病学糖尿病学

背景情况:

Helicteres angustifolia L.是一种具有已知的低血糖作用的传统中医药.
2型糖尿病 (T2DM) 是一个重大的全球健康挑战.
确定T2DM的新型治疗剂至关重要.

研究的目的:

为了研究H. angustifolia (HAEF) 的EtOAc提取物的低血糖活性.
识别和描述H. angustifolia根中的活性低血糖成分.
为传统使用H. angustifolia治疗糖尿病提供科学依据.

主要方法:

在大鼠模型中评估HAEF的链毒素诱导的T2DM (STZ).
测量生物化学参数,包括血糖,体重和器官指数.
高性能液体色谱与四极飞行时间联质谱学 (HPLC-Q-TOF-MS/MS) 用于成分分析.
特定化合物的隔离和α-葡萄糖酶抑制测定.
分子对接模拟用于预测化合物-酶相互作用.

主要成果:

在糖尿病大鼠中,HAEF显著降低了饮用和食量,控制了体重减轻,并降低了禁食血糖 (FBG).
HAEF改善了口服葡萄糖耐受性,并降低了时间血糖曲线 (AUC) 下的面积.
在HAEF中确定了21种化合物,其中4种被分离并测试了α-葡萄糖酶抑制.

结论:

HAEF表现出强大的低血糖和α-葡萄糖酶抑制活性.
这项研究是首次确定H. angustifolia根中的主要低血糖成分.
这些发现支持H. angustifolia在糖尿病管理中的治疗潜力.

关键词:

螺旋的焦叶 L. 螺旋的焦叶低血糖活动低血糖活动分子对接是分子对接.自然产品是天然产品.植物化学植物化学

更多相关视频

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis

Published on: December 8, 2023

相关概念视频

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Oral Hypoglycemic Agents: Glinides

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...